Skip to main content
TipRanks
Go Ultimate75% OFF

Medicinova (MNOV) Stock Forecast & Price Target

335 Followers
See the Price Targets and Ratings of:

MNOV Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to Medicinova in the past 3 months

MNOV Stock 12 Month Forecast

$7.33▲(425.69% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Medicinova in the last 3 months. The average price target is $7.33 with a high forecast of $10.00 and a low forecast of $6.00. The average price target represents a 425.69% change from the last price of $1.40.
Highest Price Target$10.00Average Price Target$7.33Lowest Price Target$6.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for MNOV
Price TargetArticle
H.C. Wainwright$10buy616.85%UpsideReiterated11/16/26
Maxim Group$6buy330.11%UpsideReiterated09/29/26
Roth MKM$6buy330.11%UpsideInitiated09/19/26
Lucid Capital$11buy688.53%UpsideInitiated01/05/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Medicinova

3 Months
Lander Egana Gorrono
Lander Egana GorronoH.C. Wainwright
Success Rate3/5 ratings generated profit
60%
Average Return
-8.06%

Copying Lander Egana Gorrono's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of -8.06% per trade.

1 Year
Jason McCarthy
Jason McCarthyMaxim Group
Success Rate4/6 ratings generated profit
67%
Average Return
-5.65%

Copying Jason McCarthy's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -5.65% per trade.

2 Years
Jason McCarthy
Jason McCarthyMaxim Group
Success Rate4/6 ratings generated profit
67%
Average Return
-5.65%

Copying Jason McCarthy's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of -5.65% per trade.

MNOV Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for MNOV
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy65976
Buy00000
Hold00000
Sell00000
Strong Sell00000
total65976

In the current month, MNOV has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MNOV average Analyst price target in the past 3 months is 7.33.

MNOV Financial Forecast

$-2$-1.25$-0.5$0.25$1Q2 2021Q1 2023―
Consensus$-0.23

MNOV Earnings Forecast

Next quarter’s earnings estimate for MNOV is -$0.23 with a range of ― to ―. The previous quarter’s EPS was -$0.06. MNOV beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year MNOV has Performed in-line its overall industry.

MNOV Stock Forecast FAQ

What is MNOV’s average 12-month price target, according to analysts?
Based on analyst ratings, Medicinova’s 12-month average price target is $7.33.
What is MNOV’s upside potential, based on the analysts’ average price target?
Medicinova has 425.69% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MNOV a Buy, Sell or Hold?
Medicinova has a consensus rating of Strong Buy which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Medicinova’s price target?
The average price target for Medicinova is $7.33. This is based on 3 12-month price targets, issued in the past 3 months. The highest analyst price target is $10.00, the lowest forecast is $6.00. The average price target represents a 425.69% increase from the current price of $1.395.
What do analysts say about Medicinova?
Medicinova’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of MNOV?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.